Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

7.195 -0.105 (-1.44%)
Streaming Delayed Price Updated: 12:56 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Stocks on the Launchpad: The Next 3 Market Sensations ↗
Navigate the bullish trend in the market by wagering on these three enticing market sensations likely to become multi-bagger investments 
Via InvestorPlace
News headline image
What's Going On With Ardelyx Stock After Earnings? ↗
Ardelyx reported ending 2023 with $184.3 million in cash and investments and expects full-year 2024 U.S. net product sales revenue for Ibsrela to be between $140 million and $150 million. Wedbush... 
Via Benzinga
News headline image
Where Ardelyx Stands With Analysts ↗
 
Via Benzinga
News headline image
Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket ↗
Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results. 
Via Benzinga
News headline image
Recap: Ardelyx Q4 Earnings ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Ardelyx? ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Ardelyx Posts Q4 Loss, Joins MercadoLibre, Booking Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 25 points on Friday. 
Via Benzinga
Topics Stocks
News headline image
Ardelyx Reports Mixed Q4 Results: Earnings Miss, Revenue Beat ↗
Ardelyx reported quarterly losses of 12 cents per share which missed the analyst consensus estimate of losses of 10 cents by 20%. The company reported quarterly sales of $34.36 million, beating the... 
Via Benzinga
Topics Earnings
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Wedbush Maintains Outperform Rating for Ardelyx: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Why Ardelyx Stock Is Climbing Higher ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Ardelyx Stock ↗
 
Via Benzinga
News headline image
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Analyst Upgrades: 3 Stocks Predicted to Soar In Q2 2024 ↗
Pounce on the electric surge of analyst upgrades, guiding you through market uncertainties with considerable aplomb. 
Via InvestorPlace
News headline image
3 Revolutionary Biotech Stocks Poised for 10X Surge ↗
Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities. 
Via InvestorPlace
News headline image
3 Unstoppable Russell 2000 to Buy in February ↗
These are a few companies that are within the Russell 2000 Index that offer investors great returns and a bright future. 
Via InvestorPlace
News headline image
3 Sleeper Stocks Under $15 Ready to Explode by 2029 ↗
Discover 3 under-$15 stocks primed for a 2029 explosion, from fintech disruptors to biotech pioneers tackling untreatable rare diseases. 
Via InvestorPlace
News headline image
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List ↗
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. 
Via InvestorPlace
News headline image
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024 ↗
These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns 
Via InvestorPlace
News headline image
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
Conference call scheduled for 4:30 p.m. Eastern Time 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
3 Groundbreaking Biotech Stocks to Invest in Now ↗
These are several biotech companies for investors seeking unique opportunities for great returns within the industry. 
Via InvestorPlace
News headline image
7 Small-Cap Stocks to Buy for Big Gains in 2024 ↗
Small-cap stocks are a great way to diversify your portfolio and set yourself up for some potentially dynamic gains. 
Via InvestorPlace
News headline image
3 mid-caps under $20 that Wall Street loves
MarketBeat's Stock Screener tool helped identify these three mid-cap stocks - with very bullish Wall Street sentiment - that are currently under $20 per share 
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
The 3 Best Under-$10 Stocks to Buy in January 2024 ↗
These are a few companies for investors looking for inexpensive options that still offer great earnings potential. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Nvidia, Boeing, Ardelyx, Crocs, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
 
Via Benzinga
News headline image
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.